Leap Therapeutics, Inc. LPTX
Set alert
0.77 0.00 0.00%
As of Apr 1, 9:30 AM ET
0.7351 Day range 0.7971
52-week range unavailable
- YTD
- -73.28%
- 1 year
- -76.32%
- Open
- 0.7645
- Prev close
- 0.7696
- Mkt cap
- 31.86M
- Vol
- 848.47K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7351
- High
- 0.7971
- Forward P/E
- -2.31
- Beta
- 0.22
- Short ratio
- 2.68
- Inst. own
- 40.30%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.07
- 200-d avg
- 2.66
- 1y target
- 11.38
Analyst view
Consensus: none
Price target (mean) 11.38 +1378.0% upside
Now 0.7696
- Target (low)
- 5.50
- Target (mean)
- 11.38
- Target (high)
- 16.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy3
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.38333 | -0.41 – -0.36 | -0.20 | -91.7% | 0 | 0.0% | 3 |
| Next quarter | -0.375 | -0.41 – -0.34 | -0.51 | +26.5% | 0 | 0.0% | 2 |
| Current year | -1.83 | -1.86 – -1.81 | -3.98 | +54.0% | 0 | 0.0% | 3 |
| Next year | -1.26 | -1.58 – -1.07 | -1.83 | +31.0% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 28, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| May 14, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 19, 2024 | Baird | Maintained | Outperform | Outperform |
| Mar 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 20, 2023 | Mizuho | Maintained | Buy | Buy |
| Nov 14, 2023 | Raymond James | Maintained | Outperform | Outperform |
| Aug 15, 2023 | Baird | Maintained | Outperform | Outperform |
| Aug 15, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 13, 2023 | Raymond James | Maintained | Outperform | Outperform |
| Jun 23, 2023 | Raymond James | Maintained | Outperform | Outperform |